Results 131 to 140 of about 18,738 (216)

Reducing complexity in International Bladder Cancer Group intermediate‐risk non‐muscle‐invasive bladder cancer stratification: a three‐factor approach

open access: yesBJU International, Volume 138, Issue 2, Page 244-249, August 2026.
Objectives To evaluate whether a simplified risk model preserves the prognostic performance of the International Bladder Cancer Group (IBCG) five‐factor risk stratification model in intermediate‐risk (IR) non‐muscle‐invasive bladder cancer (NMIBC). Patients and Methods We performed a multicentre retrospective analysis of 2822 patients with IR NMIBC ...
Jayant Siva   +12 more
wiley   +1 more source

Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer-A Pilot Study. [PDF]

open access: yesFront Surg, 2021
Chai CA   +9 more
europepmc   +1 more source

Surveillance patterns in non‐muscle‐invasive bladder cancer across risk groups: a real‐world analysis

open access: yesBJU International, Volume 138, Issue 2, Page 257-266, August 2026.
Objective To provide insight into real‐world surveillance practices for patients with low‐risk (LR), intermediate‐risk (IR), and (very) high‐risk (HR) non‐muscle invasive bladder cancer (NMIBC). Patients and Methods Cystoscopy surveillance patterns were analysed using real‐world data from two population‐based cohort studies in the Netherlands ...
Lisa M. C. van Hoogstraten   +6 more
wiley   +1 more source

First‐In‐Human Study: Dose Expansion of E7130 in Urothelial Carcinoma and Squamous Cell Carcinoma of the Head and Neck

open access: yesCancer Science, Volume 117, Issue 8, Page 2247-2258, August 2026.
The dose escalation part of the first‐in‐human study of E7130 in patients with advanced solid tumors determined the Recommended Phase 2 Dose of E7130 (480 μg/m2 Q3W). The dose expansion part (presented here) examined safety/preliminary efficacy in patients with squamous cell carcinoma of the head and neck and urothelial carcinoma.
Nobuaki Matsubara   +15 more
wiley   +1 more source

Harnessing Exhaled Breath for Lung Cancer Early Detection—Results From the ExPeL Study

open access: yesClinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT Scalable, non‐invasive tools are critically needed to improve early lung cancer detection and optimize primary care referral pathways. We evaluated Inflammacheck, a point‐of‐care device utilizing exhaled breath condensate (EBC) H2O2 and physiological parameters with machine learning for non‐invasive lung cancer detection in a real‐world ...
Danita Kasi Patel   +7 more
wiley   +1 more source

Artificial Intelligence-Assisted Urine Cytology for Noninvasive Detection of Muscle-Invasive Urothelial Carcinoma: A Multi-Center Diagnostic Study with Prospective Validation. [PDF]

open access: yesAdv Sci (Weinh)
Shen R   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy